Latest filing published 03 Feb 2025 for Serina Therapeutics, Inc., €4.8M.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Juvenescence Ltd: trading record in brief
All filings by Juvenescence Ltd on record concern Serina Therapeutics, Inc. In total, 5 filings cover trades dated from 13 August 2019 to 31 January 2025.
Purchases make up the whole of the open-market record (1 purchase). No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants and 1 option exercise.
Most recently, on 3 February 2025, the filings show a share grant worth €4.8M in Serina Therapeutics, Inc. The most recent open-market purchase was published on 15 August 2019, 2,643 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 8 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Juvenescence Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 500,000 shares@ US$10.0033.7% of flowCommon StockSEC:0001104659-25-008610:1
- 500,000 shares@ US$10.0034.0% of flowCommon StockSEC:0001104659-25-008610:2
- 377,865 shares@ US$13.20100.0% of flowCommon StockSEC:0001104659-25-008610:0
- 16,447,500 shares0Common StockSEC:0001104659-23-035606:0
- 19,000 sharesCommon StockSEC:0000908662-19-000177:0Canonical exit: 11 Nov 2019 (T+90)
5 of 5 declarations
